Alzheimers Corporation announces its new and improved" web site

Alzheimers Corporation announces its new and improved" website, www.AlzheimersCorp.com, redesigned to be easier to read, easier to navigate and more informative.

WHAT REASON DO YOU HAVE TO CHECK OUT www.alzheimerscorp.com?

What category do you fall in?

Are you an investor, interested in start-up companies with growth potential and desiring the opportunity to use your funds to make a difference"?

Are you a medical, geriatric or nursing home professional searching the web for alternative treatments and approaches to Alzheimers disease and other forms of dementia?

Are you the caregiver of an Alzheimers patient, seeking support, encouragement, information or treatment alternatives for your loved one?

Are you an individual who, for whatever reason, seeks to research Alzheimers disease and related illnesses and is interested in a researchers perspective?

Are to seeking to learn more about a supplement called Memory Support", originally developed for the Alzheimers patient, and now being discovered to be of great benefit to individuals in their normal, active lives?

Alzheimers Corporation announces its new and improved" website, www.AlzheimersCorp.com, redesigned to be easier to read, easier to navigate and more informative. Increased font size and some graphical changes make it easier to read" and increase the speed at which each page loads" according to Michael C. Carter, website designer.
   
The President and Founder of Alzheimers Corporation, Dr. William K. Summers, is a pioneer of Alzheimers disease research. In 1986, research that he published led to the granting of a U.S. Patent, and the eventual FDA approval of Tacrine (Cognex ) as the first drug deemed safe and effective for the treatment of Alzheimers disease. Dr. Summers has continued his research, and currently holds 11 patents (with one pending) for his innovative work in the evaluation and treatment of the disease. This website is a reflection of both this research, and Dr. Summers continued dedication to the diagnosis and care of the memory-impaired elderly through proper and rapid diagnosis, aggressive treatment with currently available drugs and neuroceuticals, while providing substantial savings to patients and families who are facing long-term care costs.

Founded in 1999, Alzheimers Corporation is dedicated to the diagnosis and care of the memory-impaired elderly within the community. The mission of Alzheimers Corporation is to improve quality of life for both patient and caregiver through proper and rapid diagnosis, aggressive treatment with currently available drugs and neuroceuticals, while providing substantial savings to patients and families who are facing long-term care costs. Currently, Dr. Summers focus has been directed toward raising the capital necessary for production of the second neuroceutical.